We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Doxycycline Tablets 50mg, 75mg and 100mg in the U.S. market.
Israel-based Teva has announced that the U.S. FDA has granted tentative approval for its abbreviated new drug application (ANDA) for Simvastatin tablets -- the generic equivalent of Merck's Zocor.
The administration of parenteral penicillin to children with suspected meningococcal disease may increase the rate of morbidity if the drugs are given before hospital admission, according to a study published in the British Medical Journal.
Cuban health authorities approved the use of the first monoclonal antibody obtained from transgenic plants in the country, the Cuban News Agency (ACN) reported on Wednesday.
The Mukesh Ambani-controlled Reliance Group is lining up big initiatives in the life sciences business this fiscal, by way of its arm Reliance Life Sciences (RLS).
The European Commission called on EU governments to decide this week whether to build a joint stockpile of anti-viral drugs to prepare for a feared flu pandemic later this year.
European parliamentarians have voted through new rules to develop safer and more effective medicines for children, which are expected to come into force in January.